AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
PHARMACEUTICALS ANNOUNCES FORMATION OF ANIMAL HEALTH COMPANY.
(Full text of a statement. Contact details below.)
( BW)(PA-VGX-PHARMACEUTICALS) VGX Pharmaceuticals Announces Formation of Animal Health Company
BLUE BELL, Pa.--(BUSINESS WIRE)--May 31, 2007--VGX Pharmaceuticals Inc. ("VGX") announced today that it has formed a wholly owned subsidiary, VGX Animal Health, Inc. ("VGX AH"). The newly established company will include the animal health intellectual property and technology that came to VGX as a result of its acquisition of ADViSYS in February of this year. Additionally, VGX AH will have access to VGX's adaptive electroporation device, Cellectra(TM) for all animal health applications.
The VGX AH pipeline includes proprietary Growth Hormone Releasing Hormone ("GHRH") plasmid technology for major food and companion animals. The company's lead product, Life Tide SW5(TM) a GHRH porcine product, is currently in registration in Australia. Also in Phase II of development are canine GHRH products for renal failure and cancer related cachexia and anemia. VGX AH has multiple product candidates in Phase I, including indications for equine laminitis and arthritis.
VGX AH will be seeking alliance partners to help in its development and commercialization efforts in major markets throughout the world.
Dr. J. Joseph Kim, President and CEO of VGX Pharmaceuticals, ...
- VGX Pharmaceuticals Announces Formation of Animal Health Company.
- Press release article from: Business Wire May 31, 2007 700+ words
...BELL, Pa. -- VGX Pharmaceuticals Inc. ("VGX...Health, Inc. ("VGX AH"). The newly...and arthritis. VGX AH will be seeking...President and CEO of VGX Pharmaceuticals, commented, "The formation of VGX AH will allow us to...
- VGX PHARMACEUTICALS AND ADVISYS ANNOUNCE MERGER AGREEMENT.
- News wire article from: AsiaPulse News February 27, 2007 700+ words
...BUSINESS WIRE)--Feb. 26, 2007--VGX Pharmaceuticals Inc., a privately held biopharmaceutical...manufacturing capabilities will be added to VGX Pharmaceuticals' newly created Immune Therapeutics...Joseph Kim, President and CEO of VGX Pharmaceuticals. "The acquisition of ADViSYS...
- VGX Pharmaceuticals and ADViSYS Announce Merger Agreement: Creation of VGX...
- Press release article from: Business Wire February 26, 2007 700+ words
...amp; THE WOODLANDS, Texas -- VGX Pharmaceuticals Inc., a privately held biopharmaceutical...manufacturing capabilities will be added to VGX Pharmaceuticals' newly created Immune Therapeutics...Joseph Kim, President and CEO of VGX Pharmaceuticals. "The acquisition of ADViSYS...
- VGX PHARMACEUTICALS ANNOUNCES ISSUANCE OF TWO KEY U.S. PATENTS.
- News wire article from: AsiaPulse News July 12, 2007 700+ words
...Contact details below.) (BW)(PA-VGX-PHARMACEUTICALS) VGX Pharmaceuticals Announces Issuance of Two Key U.S...BUSINESS WIRE)--July 11, 2007--VGX Pharmaceuticals today announced that it has been granted...
- VGX Pharmaceuticals Announces Successful Completion of the First Human Study to...
- Press release article from: Business Wire December 27, 2007 700+ words
BLUE BELL, Pa. -- VGX Pharmaceuticals announced today the successful...is a major milestone for VGX Pharmaceuticals," stated Dr. J. Joseph...platform." Over the years, VGX Pharmaceuticals has established itself as...
- VGX PHARMACEUTICALS RECEIVES US$1.9 MLN CONTRACT FROM U.S. GOV'T.
- News wire article from: AsiaPulse News September 11, 2007 700+ words
...Contact details below.) (BW)(PA-VGX-PHARMACEUTICALS) VGX Pharmaceuticals Receives .9 Million Contract from U...Pennsylvania (BUSINESS WIRE) Sept 10, 2007 - VGX Pharmaceuticals announced today that it has been awarded...
- VGX Pharmaceuticals announces filings of two separate INDs covering novel DNA...
- Press release article from: Business Wire May 19, 2008 700+ words
BLUE BELL, Pa. -- VGX Pharmaceuticals announced today that it...development platform." VGX Pharmaceuticals' SynCon[TM] DNA vaccine...CELLECTRA[R] device. About VGX Pharmaceuticals VGX Pharmaceuticals is a...
- VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral...
- Press release article from: Business Wire September 29, 2008 700+ words
...dose study BLUE BELL, Pa. -- VGX Pharmaceuticals, a biopharmaceutical company that...tolerated in humans. As a result, VGX Pharmaceuticals and VGX International, a Korean...RA patients, to be conducted by VGX Pharmaceuticals, and one for T1D patients, to...